RRAS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.32036612146658E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.27817764653082E-13 |
Normal-vs-Stage2 |
4.98170000029496E-07 |
Normal-vs-Stage3 |
1.33340000152415E-08 |
Normal-vs-Stage4 |
3.04620000002309E-07 |
Stage1-vs-Stage2 |
5.962400E-01 |
Stage1-vs-Stage3 |
6.258600E-01 |
Stage1-vs-Stage4 |
5.991000E-01 |
Stage2-vs-Stage3 |
9.352200E-01 |
Stage2-vs-Stage4 |
4.306200E-01 |
Stage3-vs-Stage4 |
4.474200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.22835116814713E-14 |
Normal-vs-AfricanAmerican |
8.60460003249131E-09 |
Normal-vs-Asian |
8.024600E-04 |
Caucasian-vs-AfricanAmerican |
7.914800E-01 |
Caucasian-vs-Asian |
7.968400E-01 |
AfricanAmerican-vs-Asian |
8.370800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.99840144432528E-15 |
Normal-vs-Female |
3.91949994682506E-09 |
Male-vs-Female |
2.322100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.11669995472852E-09 |
Normal-vs-Age(41-60Yrs) |
9.28646048947712E-12 |
Normal-vs-Age(61-80Yrs) |
7.56394946677119E-13 |
Normal-vs-Age(81-100Yrs) |
1.875760E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.258950E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.594750E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.269400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.184800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.743800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.713000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.063200E-03 |
Normal-vs-Grade 2 |
2.19209994600789E-09 |
Normal-vs-Grade 3 |
2.06568095961757E-12 |
Normal-vs-Grade 4 |
5.6585847119095E-12 |
Grade 1-vs-Grade 2 |
8.973200E-01 |
Grade 1-vs-Grade 3 |
5.343800E-01 |
Grade 1-vs-Grade 4 |
2.589400E-01 |
Grade 2-vs-Grade 3 |
3.419200E-01 |
Grade 2-vs-Grade 4 |
6.535800E-02 |
Grade 3-vs-Grade 4 |
2.001800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.52409995313985E-09 |
Normal-vs-ccB subtype |
3.10940162506768E-12 |
ccA subtype-vs-ccB subtype |
6.019700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.11260001212088E-10 |
Normal-vs-N1 |
3.544600000005E-05 |
N0-vs-N1 |
6.640800E-01 |
|
|